accurate answers
# beneficiaries targeted
# beneficiaries participating
# beneficiaries who declined MTM
# beneficiaries who disenrolled
Total drug cost PMPM per patient receiving MTM services Ans✓✓✓
Plan MTM reporting requirements for 2006
Plans to report details on their MTM programs, and will work with other
plans and pharmacy organizations to develop measures that can be used
to evaluate programs.
Plans must report
79% Ans✓✓✓ Approximately ___% of the current programs target
beneficiaries with a minimum of three chronic diseases, compared to
72% requiring a minimum of three chronic conditions in 2010.
Other with more than 10% is kidney dis, osteoarthritis, Alzheimer's
80% Ans✓✓✓ Medicare beneficiaries with four or more chronic
conditions account for ___% of Medicare spending, which totaled $402
billion in 2006.
Complex drug therapy
Cost-efficacy management
Drug therapy indications
, Drug therapy efficacy
Drug therapy safety
Drug therapy compliance
Address problems or concerns that the patient may be experiencing
Improve patients' knowledge of their medication
Empower patients to self-manage their medications and their health
condition(s)
Build professional relationship
*Clincal appropriateness, duplication, untreated disease, suboptimal
dosage Ans✓✓✓ MTR is designed to
collecting (patient-specific information)
assessing (medication therapies to identify medication-related problems)
developing (a prioritized list of medication-related problems)
creating (a plan to resolve them)